422 related articles for article (PubMed ID: 15843498)
1. Xrcc3 induces cisplatin resistance by stimulation of Rad51-related recombinational repair, S-phase checkpoint activation, and reduced apoptosis.
Xu ZY; Loignon M; Han FY; Panasci L; Aloyz R
J Pharmacol Exp Ther; 2005 Aug; 314(2):495-505. PubMed ID: 15843498
[TBL] [Abstract][Full Text] [Related]
2. Regulation of cisplatin resistance and homologous recombinational repair by the TFIIH subunit XPD.
Aloyz R; Xu ZY; Bello V; Bergeron J; Han FY; Yan Y; Malapetsa A; Alaoui-Jamali MA; Duncan AM; Panasci L
Cancer Res; 2002 Oct; 62(19):5457-62. PubMed ID: 12359753
[TBL] [Abstract][Full Text] [Related]
3. Low doses of alpha particles do not induce sister chromatid exchanges in bystander Chinese hamster cells defective in homologous recombination.
Nagasawa H; Wilson PF; Chen DJ; Thompson LH; Bedford JS; Little JB
DNA Repair (Amst); 2008 Mar; 7(3):515-22. PubMed ID: 18182331
[TBL] [Abstract][Full Text] [Related]
4. The involvement of XPC protein in the cisplatin DNA damaging treatment-mediated cellular response.
Wang G; Dombkowski A; Chuang L; Xu XX
Cell Res; 2004 Aug; 14(4):303-14. PubMed ID: 15353127
[TBL] [Abstract][Full Text] [Related]
5. In vitro evidence for homologous recombinational repair in resistance to melphalan.
Wang ZM; Chen ZP; Xu ZY; Christodoulopoulos G; Bello V; Mohr G; Aloyz R; Panasci LC
J Natl Cancer Inst; 2001 Oct; 93(19):1473-8. PubMed ID: 11584063
[TBL] [Abstract][Full Text] [Related]
6. Collaborative roles of gammaH2AX and the Rad51 paralog Xrcc3 in homologous recombinational repair.
Sonoda E; Zhao GY; Kohzaki M; Dhar PK; Kikuchi K; Redon C; Pilch DR; Bonner WM; Nakano A; Watanabe M; Nakayama T; Takeda S; Takami Y
DNA Repair (Amst); 2007 Mar; 6(3):280-92. PubMed ID: 17123873
[TBL] [Abstract][Full Text] [Related]
7. Differential regulation of DNA repair protein Rad51 in human tumour cell lines exposed to doxorubicin.
Koehn H; Magan N; Isaacs RJ; Stowell KM
Anticancer Drugs; 2007 Apr; 18(4):419-25. PubMed ID: 17351394
[TBL] [Abstract][Full Text] [Related]
8. Xrcc3 is recruited to DNA double strand breaks early and independent of Rad51.
Forget AL; Bennett BT; Knight KL
J Cell Biochem; 2004 Oct; 93(3):429-36. PubMed ID: 15372620
[TBL] [Abstract][Full Text] [Related]
9. Homologous-pairing activity of the human DNA-repair proteins Xrcc3.Rad51C.
Kurumizaka H; Ikawa S; Nakada M; Eda K; Kagawa W; Takata M; Takeda S; Yokoyama S; Shibata T
Proc Natl Acad Sci U S A; 2001 May; 98(10):5538-43. PubMed ID: 11331762
[TBL] [Abstract][Full Text] [Related]
10. The carboxyl-terminal of BRCA1 is required for subnuclear assembly of RAD51 after treatment with cisplatin but not ionizing radiation in human breast and ovarian cancer cells.
Zhou C; Huang P; Liu J
Biochem Biophys Res Commun; 2005 Oct; 336(3):952-60. PubMed ID: 16165098
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of glutathione synthesis reverses Bcl-2-mediated cisplatin resistance.
Rudin CM; Yang Z; Schumaker LM; VanderWeele DJ; Newkirk K; Egorin MJ; Zuhowski EG; Cullen KJ
Cancer Res; 2003 Jan; 63(2):312-8. PubMed ID: 12543781
[TBL] [Abstract][Full Text] [Related]
12. Polymorphism of the homologous recombination repair genes RAD51 and XRCC3 in breast cancer.
Krupa R; Synowiec E; Pawlowska E; Morawiec Z; Sobczuk A; Zadrozny M; Wozniak K; Blasiak J
Exp Mol Pathol; 2009 Aug; 87(1):32-5. PubMed ID: 19426727
[TBL] [Abstract][Full Text] [Related]
13. Microsatellite instability, apoptosis, and loss of p53 function in drug-resistant tumor cells.
Anthoney DA; McIlwrath AJ; Gallagher WM; Edlin AR; Brown R
Cancer Res; 1996 Mar; 56(6):1374-81. PubMed ID: 8640828
[TBL] [Abstract][Full Text] [Related]
14. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P
Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094
[TBL] [Abstract][Full Text] [Related]
15. Extensive chromosomal instability in Rad51d-deficient mouse cells.
Smiraldo PG; Gruver AM; Osborn JC; Pittman DL
Cancer Res; 2005 Mar; 65(6):2089-96. PubMed ID: 15781618
[TBL] [Abstract][Full Text] [Related]
16. Cross-resistance to death ligand-induced apoptosis in cisplatin-selected HeLa cells associated with overexpression of DDB2 and subsequent induction of cFLIP.
Sun CL; Chao CC
Mol Pharmacol; 2005 Apr; 67(4):1307-14. PubMed ID: 15644494
[TBL] [Abstract][Full Text] [Related]
17. Hypersensitivity of Brca1-deficient MEF to the DNA interstrand crosslinking agent mitomycin C is associated with defect in homologous recombination repair and aberrant S-phase arrest.
Yun J; Zhong Q; Kwak JY; Lee WH
Oncogene; 2005 Jun; 24(25):4009-16. PubMed ID: 15782115
[TBL] [Abstract][Full Text] [Related]
18. Defective DNA strand break repair after DNA damage in prostate cancer cells: implications for genetic instability and prostate cancer progression.
Fan R; Kumaravel TS; Jalali F; Marrano P; Squire JA; Bristow RG
Cancer Res; 2004 Dec; 64(23):8526-33. PubMed ID: 15574758
[TBL] [Abstract][Full Text] [Related]
19. Mitotic arrest deficient 2 expression induces chemosensitization to a DNA-damaging agent, cisplatin, in nasopharyngeal carcinoma cells.
Cheung HW; Jin DY; Ling MT; Wong YC; Wang Q; Tsao SW; Wang X
Cancer Res; 2005 Feb; 65(4):1450-8. PubMed ID: 15735033
[TBL] [Abstract][Full Text] [Related]
20. Cellular localization of human Rad51C and regulation of ubiquitin-mediated proteolysis of Rad51.
Bennett BT; Knight KL
J Cell Biochem; 2005 Dec; 96(6):1095-109. PubMed ID: 16215984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
